Xie H Erin 4
4 · BlackRock Health Sciences Trust · Filed Feb 4, 2025
Insider Transaction Report
Form 4
Xie H Erin
Other
Transactions
- Exercise/Conversion
Common Stock
2025-01-31+13,471.132→ 13,471.132 total - Award
Phantom Shares
2025-01-31$40.92/sh+9,530.372$389,983→ 9,530.372 total→ Common Stock (9,530.372 underlying) - Disposition to Issuer
Common Stock
2025-01-31$40.92/sh−13,471.132$551,239→ 0 total - Exercise/Conversion
Phantom Shares
2025-01-31−2,773.557→ 5,547.114 total→ Common Stock (2,773.557 underlying) - Exercise/Conversion
Phantom Shares
2025-01-31−4,587.872→ 4,587.872 total→ Common Stock (4,587.872 underlying) - Exercise/Conversion
Phantom Shares
2025-01-31−6,109.703→ 0 total→ Common Stock (6,109.703 underlying)
Footnotes (5)
- [F1]A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash.
- [F2]As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
- [F3]As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
- [F4]As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
- [F5]These phantom shares vest in equal installments on each of the first three anniversaries of the award.